|
Friday 26th September 2008 |
Text too small? |
IRG sees "significant" synergies with Ellerie, said managing director Brent King, in a statement. No price was given.
IRG stock, which trades infrequently, changed hands at 5 cents today and has declined 75% this year. The company posted a full-year loss of NZ$15.2 million loss after a slump in the value of its investments in Dorchester Pacific investment and ICP Biotechnology, which was placed in receivership.
Last month, the company named former Finance Minister Bill Birch as chairman, taking over from King, who stayed on as managing director.
![]() |
Compare
deposit rates and view special rates online or sign up to the Deposit Rates news alerts. |
No comments yet
RAK - 1H26: Strong first half growth and strategic momentum
Green Cross Health Interim Results to 30 September 2025
Devon Funds Morning Note - 28 November 2025
November 28th Morning Report
Pacific Edge Appoints Chief Commercial Officer
Ryman Healthcare reports 1H26 results
Tower reports record FY25 result, increased dividends
NZ King Salmon Investments Ltd releases FY25 (Sept) results
RBNZ - OCR lowered to 2.25%
SVR - Savor Interim Results and Trading Update